| Respiratory system | |||||
|---|---|---|---|---|---|
| Respiratory system / Respiratory depression, respiratory distress syndrome and apnoea | |||||
| doxapram hydrochloride | Specialist Initiated for Hospital use Only | ||||
| Respiratory system / Airways disease, obstructive | |||||
| aclidinium bromide | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Eklira (Covis Pharma GmbH) | Non-Formulary (or under review) | ||||
| aclidinium bromide with formoterol | Formulary | ||||
| aminophylline | Specialist Initiated for Hospital use Only | ||||
| Solution for injection | |||||
| Aminophylline (Non-proprietary) | Specialist Initiated for Hospital use Only | ||||
| bambuterol hydrochloride | Non-Formulary (or under review) | ||||
| beclometasone dipropionate | Formulary | ||||
| Pressurised inhalation | |||||
| Beclu (Lupin Healthcare (UK) Ltd) | Formulary | ||||
| Clenil Modulite (Chiesi Ltd) | Formulary | ||||
| Kelhale (Cipla EU Ltd) | Specialist Initiated in hospital and continued in Primary Care | ||||
| Qvar (Teva UK Ltd) | Non-Formulary (or under review) | ||||
| Qvar Autohaler (Teva UK Ltd) | Non-Formulary (or under review) | ||||
| Qvar Easi-Breathe (Teva UK Ltd) | Non-Formulary (or under review) | ||||
| Soprobec (Glenmark Pharmaceuticals Europe Ltd) | Non-Formulary (or under review) | ||||
| beclometasone with formoterol | Formulary | ||||
| beclometasone with formoterol and glycopyrronium | Specialist Initiated in hospital and continued in Primary Care | ||||
| budesonide | Formulary |
NICE TA708 |
|||
| Inhalation powder | |||||
| Pulmicort Turbohaler (AstraZeneca UK Ltd) | Formulary | ||||
| budesonide with formoterol | Formulary | ||||
| Inhalation powder | |||||
| DuoResp Spiromax (Teva UK Ltd) | Non-Formulary (or under review) | ||||
| ciclesonide | Non-Formulary (or under review) | ||||
| Pressurised inhalation | |||||
| Alvesco (Covis Pharma GmbH) | Non-Formulary (or under review) | ||||
| ephedrine hydrochloride | Specialist Initiated for Hospital use Only | ||||
| fluticasone | Formulary | ||||
| Pressurised inhalation | |||||
| Flixotide Evohaler (GlaxoSmithKline UK Ltd) | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Flixotide Accuhaler (GlaxoSmithKline UK Ltd) | Formulary | ||||
| fluticasone with formoterol | Non-Formulary (or under review) | ||||
| Pressurised inhalation | |||||
| Flutiform (Napp Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
| fluticasone with salmeterol | Formulary | ||||
| Pressurised inhalation | |||||
| AirFluSal (Sandoz Ltd) | Non-Formulary (or under review) | ||||
| Aloflute (Viatris UK Healthcare Ltd) | Non-Formulary (or under review) | ||||
| Avenor (Zentiva Pharma UK Ltd) | Non-Formulary (or under review) | ||||
| Combisal (Aspire Pharma Ltd) | Non-Formulary (or under review) | ||||
| Sereflo (Cipla EU Ltd) | Formulary | ||||
| Seretide Evohaler (GlaxoSmithKline UK Ltd) | Non-Formulary (or under review) | ||||
| Sirdupla (Viatris UK Healthcare Ltd) | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| AirFluSal Forspiro (Sandoz Ltd) | Non-Formulary (or under review) | ||||
| Campona Airmaster (Genesis Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
| Fixkoh Airmaster (Genus Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
| Fusacomb Easyhaler (Orion Pharma (UK) Ltd) | Formulary | ||||
| Sereflo Ciphaler (Cipla EU Ltd) | Formulary | ||||
| Seretide Accuhaler (GlaxoSmithKline UK Ltd) | Formulary | ||||
| Stalpex (Glenmark Pharmaceuticals Europe Ltd) | Non-Formulary (or under review) | ||||
| fluticasone with umeclidinium and vilanterol | Specialist Initiated in hospital and continued in Primary Care | ||||
| fluticasone with vilanterol | Formulary | ||||
| formoterol fumarate | Non-Formulary (or under review) | ||||
| Pressurised inhalation | |||||
| Atimos Modulite (Chiesi Ltd) | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Easyhaler (Orion Pharma (UK) Ltd) | Non-Formulary (or under review) | ||||
| Foradil (Novartis Pharmaceuticals UK Ltd) | Non-Formulary (or under review) | ||||
| Oxis Turbohaler (AstraZeneca UK Ltd) | Non-Formulary (or under review) | ||||
| glycopyrronium bromide | Specialist Initiated for Hospital use Only | ||||
| Solution for injection | |||||
| Glycopyrronium bromide (Non-proprietary) | Specialist Initiated for Hospital use Only | ||||
| Inhalation powder | |||||
| Seebri Breezhaler (Novartis Pharmaceuticals UK Ltd) | Non-Formulary (or under review) | ||||
| glycopyrronium with formoterol fumarate | |||||
| Pressurised inhalation | |||||
| Bevespi Aerosphere (AstraZeneca UK Ltd) | Formulary | ||||
| glycopyrronium with indacaterol | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Ultibro Breezhaler (Novartis Pharmaceuticals UK Ltd) | Non-Formulary (or under review) | ||||
| indacaterol | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Onbrez Breezhaler (Novartis Pharmaceuticals UK Ltd) | Non-Formulary (or under review) | ||||
| ipratropium bromide | Formulary | ||||
| Pressurised inhalation | |||||
| Atrovent (Boehringer Ingelheim Ltd) | Formulary | ||||
| Inhalvent (Alissa Healthcare Research Ltd) | Non-Formulary (or under review) | ||||
| Nebuliser liquid | |||||
| Ipratropium bromide (Non-proprietary) | Formulary | ||||
| Atrovent UDV (Boehringer Ingelheim Ltd) | Formulary | ||||
| Spray | |||||
| Rinatec (Sanofi Consumer Healthcare) | Non-Formulary (or under review) | ||||
| mometasone furoate | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Asmanex Twisthaler (Organon Pharma (UK) Ltd) | Non-Formulary (or under review) | ||||
| montelukast | Formulary | ||||
| omalizumab | Specialist Initiated for Hospital use Only |
NICE TA278 NICE TA339 |
|||
| roflumilast | Specialist Initiated in hospital and continued in Primary Care |
NICE TA461 |
|||
| salbutamol | Formulary | ||||
| Solution for injection | |||||
| Ventolin (GlaxoSmithKline UK Ltd) | Specialist Initiated for Hospital use Only | ||||
| Inhalation powder | |||||
| Ventolin Accuhaler (GlaxoSmithKline UK Ltd) | Formulary | ||||
| salmeterol | Non-Formulary (or under review) | ||||
| Pressurised inhalation | |||||
| Neovent (Kent Pharma (UK) Ltd) | Non-Formulary (or under review) | ||||
| Serevent Evohaler (GlaxoSmithKline UK Ltd) | Non-Formulary (or under review) | ||||
| Soltel (Cipla EU Ltd) | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Serevent Accuhaler (GlaxoSmithKline UK Ltd) | Non-Formulary (or under review) | ||||
| terbutaline sulfate | Formulary | ||||
| Inhalation powder | |||||
| Bricanyl Turbohaler (AstraZeneca UK Ltd) | Formulary | ||||
| theophylline | Specialist Initiated in hospital and continued in Primary Care | ||||
| tiotropium | Formulary | ||||
| Inhalation powder | |||||
| Acopair (Viatris UK Healthcare Ltd) | Non-Formulary (or under review) | ||||
| Braltus (Teva UK Ltd) | Non-Formulary (or under review) | ||||
| Spiriva (Boehringer Ingelheim Ltd) | Non-Formulary (or under review) | ||||
| Tiogiva (Glenmark Pharmaceuticals Europe Ltd) | Non-Formulary (or under review) | ||||
| Inhalation solution | |||||
| Spiriva Respimat (Boehringer Ingelheim Ltd) | Formulary | ||||
| tiotropium with olodaterol | Non-Formulary (or under review) | ||||
| umeclidinium | Non-Formulary (or under review) | ||||
| Inhalation powder | |||||
| Incruse Ellipta (GlaxoSmithKline UK Ltd) | Non-Formulary (or under review) | ||||
| umeclidinium with vilanterol | Formulary | ||||
| Respiratory system / Cough and congestion | |||||
| citric acid | Non-Formulary (or under review) | ||||
| Oral solution | |||||
| Citric acid (Non-proprietary) | Non-Formulary (or under review) | ||||
| codeine phosphate | Non-Formulary (or under review) | ||||
| Oral solution | |||||
| Codeine phosphate (Non-proprietary) | Non-Formulary (or under review) | ||||
| eucalyptus with menthol | Non-Formulary (or under review) | ||||
| Respiratory system / Allergic conditions | |||||
| acrivastine | Non-Formulary (or under review) | ||||
| alimemazine tartrate | Non-Formulary (or under review) | ||||
| bilastine | Non-Formulary (or under review) | ||||
| cetirizine hydrochloride | Formulary | ||||
| chlorphenamine maleate | Formulary | ||||
| cyproheptadine hydrochloride | Non-Formulary (or under review) | ||||
| desloratadine | Non-Formulary (or under review) | ||||
| fexofenadine hydrochloride | Formulary | ||||
| grass pollen extract | Specialist Initiated in hospital and continued in Primary Care | ||||
| hydroxyzine hydrochloride | Formulary | ||||
| ketotifen | Non-Formulary (or under review) | ||||
| Oral solution | |||||
| Zaditen (CD Pharma Srl) | Non-Formulary (or under review) | ||||
| levocetirizine hydrochloride | Non-Formulary (or under review) | ||||
| loratadine | Formulary | ||||
| mizolastine | Non-Formulary (or under review) | ||||
| promethazine hydrochloride | Formulary | ||||
| rupatadine | Non-Formulary (or under review) | ||||
| Respiratory system / Anaphylaxis | |||||
| adrenaline/epinephrine | Specialist Initiated for Hospital use Only | ||||
| Solution for injection | |||||
| EpiPen (Viatris UK Healthcare Ltd) | Formulary | ||||
| Jext (ALK-Abello Ltd) | Formulary | ||||
| chlorphenamine maleate | Formulary | ||||
| Respiratory system / Angioedema | |||||
| C1-esterase inhibitor | Specialist Initiated in hospital and continued in Primary Care | ||||
| conestat alfa | Non-Formulary (or under review) | ||||
| icatibant | Non-Formulary (or under review) | ||||
| Respiratory system / Conditions affecting sputum viscosity | |||||
| acetylcysteine | Specialist Initiated in hospital and continued in Primary Care | ||||
| Solution for infusion | |||||
| Acetylcysteine (Non-proprietary) | Formulary | ||||
| Eye drops | |||||
| Ilube (Rayner Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
| carbocisteine | Formulary | ||||
| erdosteine | Non-Formulary (or under review) | ||||
| Respiratory system / Cystic fibrosis | |||||
| dornase alfa | Specialist Initiated in hospital and continued in Primary Care | ||||
| ivacaftor | Specialist Initiated for Hospital use Only | ||||
| mannitol | Specialist Initiated in hospital and continued in Primary Care |
NICE TA266 |
|||